Case of MOG-IgG-associated disease with ankylosing spondylitis: A rare coexistence.
| Autor: | Türk SM; Department of Internal Medicine, Division of Rheumatology, Sakarya University Faculty of Medicine, Sakarya, Türkiye., Kotan D; Department of Neurology, Sakarya University Faculty of Medicine, Sakarya, Türkiye., Gönüllü E; Department of Internal Medicine, Division of Rheumatology, Sakarya University Faculty of Medicine, Sakarya, Türkiye., Öztürk Z; Department of Internal Medicine, Division of Rheumatology, Sakarya University Faculty of Medicine, Sakarya, Türkiye., Karataş D; Department of Internal Medicine, Division of Rheumatology, Sakarya University Faculty of Medicine, Sakarya, Türkiye. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Turkish journal of physical medicine and rehabilitation [Turk J Phys Med Rehabil] 2022 Aug 02; Vol. 69 (4), pp. 545-548. Date of Electronic Publication: 2022 Aug 02 (Print Publication: 2023). |
| DOI: | 10.5606/tftrd.2023.9489 |
| Abstrakt: | Myelin oligodendrocyte glycoprotein-associated disease (MOGAD) is an inflammatory neurological disease. It progresses with attacks by affecting the optic nerves and spinal cord. Bilateral or recurrent optic neuritis are the most common findings in adult patients. Its association with systemic autoimmune disorders such as Sjögren syndrome, antiphospholipid syndrome, autoimmune thyroiditis, and celiac disease is rare. The first and only case of MOGAD in a patient with ankylosing spondylitis with a history of anti-tumor necrosis factor-alpha (anti-TNF-α) use was reported. Herein, we present the coexistence of MOGAD in a patient with AS who did not have a history of anti-TNF-α therapy. Competing Interests: Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article. (Copyright © 2023, Turkish Society of Physical Medicine and Rehabilitation.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|